Tacrolimus (FK 506)-induced hemolytic uremic syndrome after heart transplantation.
A case of tacrolimus (FK 506)-induced hemolytic uremic syndrome is reported. The direct implication of tacrolimus, an alternative immunosuppressant to cyclosporine, was strongly supported by the recurrence of the syndrome after a second exposure to the treatment.
Walder
B
B
Division of Surgical Intensive Care, Geneva University Hospital, Switzerland. bari@diogenes.hcuge.ch
Ricou
B
B
Suter
P M
PM
D002311:Cardiomyopathy, Dilated / Q000601:surgery; D006084:Graft Rejection / Q000188:drug therapy; D016027:Heart Transplantation / Q000276:immunology*; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000139:chemically induced; D012008:Recurrence; D016559:Tacrolimus / Q000009:adverse effects* / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D016559:Tacrolimus